Stools in pill form can counteract obesity
Faeces pills with freeze-dried stools from healthy donors can help overweight people lose weight. In March, the pills will be tested on humans.
You take fresh stools from a healthy person, mix it with a material that protects the bacteria and then sort out various undigested dietary fiber and other unnecessary matter. The valuable bacteria remain. The result is freeze-dried and stopped in pills.
And then you get – maybe – the miracle cure of the future: Bajspiller.
In the US, from March and three months onwards, a group of obese subjects will be taking faeces-pill repectative placebo.
Promising results with mice
The trial is being conducted by researchers at Massachusetts General Hospital. It is the first official, clinical trial of people investigating whether healthy intestinal flora can help overweight people lose weight.
In the past, experiments with mice have shown that feces from overweight cause normal-weight mice to gain weight, while feces from healthy weight appear to help the overweight with a weight loss – even though all mice were given the same diet.
Positive effect on sclerosis and Parkinson’s
The transfer of intestinal flora from a healthy donor to a sick patient has recently been used for people with diarrhoea.
The method has, first and foremost, been recognized as an effective weapon against the life-threatening infection Clostridium difficile, which ravages in the hospital rooms and which is almost impossible to get rid of for weak patients.
But faeces transplantation has also been shown to have the potential to counteract several other ailments, including such conditions as Parkinson’s, sclerosis, diabetes, obesity, and even anxiety and depression.
Pills are preferred
The treatment is officially called fecal transplant (FMT) and has so far been performed mainly by introducing mixed feces directly into the anus. Most understandably want to eat a pill for understandable reasons, and so this treatment method is currently being investigated in several places in the world.